New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases
Abstract Dyslipidemia, characterized by elevation of plasma low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and reduction of plasma high density lipoprotein cholesterol (HDL-C), has been verified as a causal risk factor for cardiovascular diseases (CVD), leading to a high mortality ra...
Main Authors: | Xin Su, Dao-quan Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-018-0659-y |
Similar Items
-
Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
by: Pei-Yi Chen, et al.
Published: (2021-07-01) -
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
by: Anni Kumari, et al.
Published: (2021-07-01) -
Lipoprotein lipase activity is reduced in dialysis patients. Studies on possible causal factors.
by: Mahmood, Dana
Published: (2012) -
The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
by: Ren Zhang
Published: (2016-01-01) -
The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells
by: Pei-Yi Chen, et al.
Published: (2021-09-01)